Esculentoside A Attenuates Allergic Airway Inflammation via Activation of the Nrf-2 Pathway

Conclusions: This is the first study to illustrate that EsA acts as a novel Nrf-2 activator, which modulates the oxidative stress pathway to improve lung injury and ameliorate the development of airway inflammation.Int Arch Allergy Immunol 2015;167:280-290
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research